d68Ga-DOTATATE PET/CT Assessment of Cardiac Sarcoidosis

PHASE4CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

July 20, 2018

Primary Completion Date

October 2, 2019

Study Completion Date

October 2, 2019

Conditions
Cardiac Sarcoidosis
Interventions
DRUG

68Ga-DOTATATE PET/CT

5.4 mCi of 68Ga-DOTATATE will be administered by intravenous route.

DRUG

18FDG PET/CT scan

This scan will be performed as part of the planned clinical care for the patient. Dose of 18FDG will be administered intravenously in accordance with the institutional policy and accepted norms. CT attenuation scan will also be performed as part of this examination per institutional protocol.

DRUG

13NH3 PET/CT scan

This scan will be performed as part of the planned clinical care for the patient. Dose of 13NH3 will be administered intravenously in accordance with the institutional policy and accepted norms. CT attenuation scan will also be performed as part of this examination per institutional protocol.

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT03549598 - d68Ga-DOTATATE PET/CT Assessment of Cardiac Sarcoidosis | Biotech Hunter | Biotech Hunter